4.7 Review

Enhancer RNA (eRNA) in Human Diseases

期刊

出版社

MDPI
DOI: 10.3390/ijms231911582

关键词

enhancer RNA; eRNA; cancer; neurodegenerative disorder; cardiovascular disease; metabolic disease; transcriptional regulation

资金

  1. National Natural Science Foundation of China [32270708, 82203195]
  2. Shanghai Pujiang Program [21PJ1401700, 20PJ1400700]

向作者/读者索取更多资源

This review summarized recent studies on the pathological mechanisms and potential clinical utility of eRNAs in human diseases. The findings indicate the significant therapeutic potential of eRNAs in diagnosis, prognosis, and treatment.
Enhancer RNAs (eRNAs), a class of non-coding RNAs (ncRNAs) transcribed from enhancer regions, serve as a type of critical regulatory element in gene expression. There is increasing evidence demonstrating that the aberrant expression of eRNAs can be broadly detected in various human diseases. Some studies also revealed the potential clinical utility of eRNAs in these diseases. In this review, we summarized the recent studies regarding the pathological mechanisms of eRNAs as well as their potential utility across human diseases, including cancers, neurodegenerative disorders, cardiovascular diseases and metabolic diseases. It could help us to understand how eRNAs are engaged in the processes of diseases and to obtain better insight of eRNAs in diagnosis, prognosis or therapy. The studies we reviewed here indicate the enormous therapeutic potency of eRNAs across human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据